Showing results (71-80 of 113) with videos related to
Sort By:
Pageof 12
British Journal of Cancer|November 1, 1995
Importance of P450 reductase activity in determining sensitivity of breast tumour cells to the bioreductive drug, tirapazamine (SR 4233)A V Patterson, H M Barham, E C Chinje, et al.International Journal of Radiation Oncology, Biology, Physics|May 15, 1994
Comparing the anti-tumor effect of several bioreductive drugs when used in combination with photodynamic therapy (PDT)J C Bremner, J K Bradley, G E Adams, et al.British Journal of Cancer|July 17, 1998
Magnetic resonance imaging and spectroscopy of combretastatin A4 prodrug-induced disruption of tumour perfusion and energetic statusD A Beauregard, P E Thelwall, D J Chaplin, et al.International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
The response of spontaneous and transplantable murine tumors to vasoactive agents measured by 31P magnetic resonance spectroscopyP J Wood, I J Stratford, J M Sansom, et al.International Journal of Radiation Oncology, Biology, Physics|July 1, 1991
Oral (po) dosing with RSU 1069 or RB 6145 maintains their potency as hypoxic cell radiosensitizers and cytotoxins but reduces systemic toxicity compared with parenteral (ip) administration in miceS Cole, I J Stratford, J Bowler, et al.FEBS Letters|June 5, 1989
Induction of tumour hypoxia by a vasoactive agent. A combined NMR and radiobiological studyJ F Dunn, S Frostick, G E Adams, et al.International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Assessment of a range of novel nitro-aromatic radiosensitizers and bioreductive drugsE M Fielden, G E Adams, S Cole, et al.International Journal of Radiation Oncology, Biology, Physics|May 15, 1994
Radiolytic and photochemical reduction of the hypoxic cytotoxin 1,2-dihydro-8-(4-methylpiperazinyl)-4-phenylimidazo [1,2-a] pyrido [3,2-e] pyrazine 5-oxide (RB90740) and a potential mechanism for hypoxia-selective toxicityM A Naylor, B M Sutton, J Nolan, et al.International Journal of Radiation Biology|January 1, 1994
Manipulation and exploitation of the tumour environment for therapeutic benefitI J Stratford, G E Adams, J C Bremner, et al.International Journal of Radiation Oncology, Biology, Physics|May 15, 1994
31P MRS to monitor the induction of tumor hypoxia by the modification of the oxygen affinity of hemoglobin using BW 589CR Kalra, J C Bremner, P J Wood, et al.Pageof 12